Beijing Geekgene Technology Co., Ltd

This early-stage study tests a new treatment (GK02) for people with advanced solid tumors that cause fluid buildup in the belly (malignant ascites). The treatment uses the patient's own immune cells taken from that fluid, multiplied in a lab, and then given back to attack the can…

This early-phase study tests a new cell treatment called GK01 in 10 people with advanced lung or esophageal cancer that no longer responds to standard treatments. The main goal is to check safety and side effects, while also looking at how the body processes the therapy. Particip…